Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control.

Thornton, V; Lennon, D; Rasanathan, K; O'Hallahan, J; Oster, P; Stewart, J; Tilman, S; Aaberge, I; Feiring, B; Nokleby, H; +6 more... Rosenqvist, E; White, K; Reid, S; Mulholland, K; Wakefield, MJ; Martin, D; (2006) Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control. Vaccine, 24 (9). pp. 1395-400. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2005.09.043

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.vaccine.2005.09.043

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar